APA

Moosmann N., von Weikersthal L. F., Vehling-Kaiser U., Stauch M., Hass H. G., Dietzfelbinger H., Oruzio D., Klein S., Zellmann K., Decker T., Schulze M., Abenhardt W., Puchtler G., Kappauf H., Mittermüller J., Haberl C., Schalhorn A., Jung A., Stintzing S. & Heinemann V. (20110509). Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Moosmann Nicolas, von Weikersthal Ludwig Fischer, Vehling-Kaiser Ursula, Stauch Martina, Hass Holger G, Dietzfelbinger Herrmann, Oruzio Daniel, Klein Stefan, Zellmann Klaus, Decker Thomas, Schulze Mathias, Abenhardt Wolfgang, Puchtler Gerhard, Kappauf Herbert, Mittermüller Johann, Haberl Christopher, Schalhorn Andreas, Jung Andreas, Stintzing Sebastian and Heinemann Volker. 20110509. Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Moosmann N., von Weikersthal L. F., Vehling-Kaiser U., Stauch M., Hass H. G., Dietzfelbinger H., Oruzio D., Klein S., Zellmann K., Decker T., Schulze M., Abenhardt W., Puchtler G., Kappauf H., Mittermüller J., Haberl C., Schalhorn A., Jung A., Stintzing S. and Heinemann V. (20110509). Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Moosmann Nicolas, von Weikersthal Ludwig Fischer, Vehling-Kaiser Ursula, Stauch Martina, Hass Holger G, Dietzfelbinger Herrmann, Oruzio Daniel, Klein Stefan, Zellmann Klaus, Decker Thomas, Schulze Mathias, Abenhardt Wolfgang, Puchtler Gerhard, Kappauf Herbert, Mittermüller Johann, Haberl Christopher, Schalhorn Andreas, Jung Andreas, Stintzing Sebastian and Heinemann Volker. Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20110509.